Gilead Sciences, Inc. (GILD)
130.48
+0.81
(+0.62%)
USD |
NASDAQ |
May 19, 16:00
129.50
-0.98
(-0.75%)
After-Hours: 18:32
Gilead Sciences Research and Development Expense (Quarterly) : 1.354B for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.719B |
| Biogen, Inc. | 471.10M |
| AbbVie, Inc. | 2.472B |
| Moderna, Inc. | 590.00M |
| Abbott Laboratories | 767.00M |